European Organisation

Nov 13, 2024 | redjournal.org | European Organisation |Humboldt-Universität zu Berlin |Bristol Haematology |Thomas' NHS

Brief ReportArticles in PressOpen access 1Radiation Oncology, University Hospital of Muenster, Muenster, Germany 2Department of Dermatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland 3European Organisation for Research and Treatment of Cancer, Headquarters, Brussels, Belgium 4Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Athens, Greece 5Department of Dermatology, University Hospital of Bordeaux and INSERM U1312,...

Oct 24, 2024 | medicalxpress.com | European Organisation

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:Patients with advanced bladder cancer that has spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300. The drug targets changes in the FGFR3 gene that drive tumor growth in about 10%-20% of these patients.

Oct 24, 2024 | medicalxpress.com | European Organisation

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:Researchers have discovered key mutations in certain cancer cells that make them resistant to WRN inhibitors, a new class of anti-cancer drugs. The yet-to-be-published findings are presented on Friday at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.

Oct 24, 2024 | medicalxpress.com | European Organisation

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:Researchers have shown for the first time that it is possible for a specially designed 'mini-protein' to deliver a radiation dose directly to tumor cells expressing a protein on their cell surfaces called Nectin-4, which is often found in a number of different cancers.

Oct 24, 2024 | medicalxpress.com | European Organisation

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:Researchers have shown that they can accurately recreate clinical trials of new treatments using "digital twins" of real cancer patients.